NasdaqGS - Nasdaq Real Time Price USD

Orthofix Medical Inc. (OFIX)

12.99

-0.11

(-0.84%)

At close: April 26 at 4:00 PM EDT

12.99

0.00

(0.00%)

After hours: April 26 at 4:20 PM EDT

Orthofix Schedules First Quarter 2024 Earnings Release and Conference Call for May 7, 2024

LEWISVILLE, Texas, April 23, 2024--Orthofix Medical Inc. (NASDAQ:OFIX), a leading global spine and orthopedics company, today announced that it will release its first quarter 2024 financial results on Tuesday, May 7, 2024 before market open. The Company will host a conference call and webcast to review results at 8:30 a.m. ET the same day.

Business Wire 5 days ago
Orthofix Names Andres Cedron as New Chief Legal Officer

LEWISVILLE, Texas, April 16, 2024--Orthofix Medical Inc. (NASDAQ:OFIX), a leading global spine and orthopedics company, today announced that Andres Cedron has joined the company as Chief Legal Officer.

Business Wire 12 days ago
Lucas Vitale Joins Orthofix as Chief People and Business Operations Officer

LEWISVILLE, Texas, March 18, 2024--Former NuVasive executive joins Orthofix as Chief People and Business Operations Officer.

Business Wire last month
Orthofix Reports Fourth Quarter and Full Year 2023 Results

LEWISVILLE, Texas, March 05, 2024--Orthofix Medical Inc. (NASDAQ:OFIX) today reported its financial results for the fourth quarter and year ended December 31, 2023, and issued guidance for the full year 2024.

Business Wire last month
Orthofix Announces New President for Bone Growth Therapies Business

LEWISVILLE, Texas, February 29, 2024--Orthofix realigns its Spine business unit and appoints Jason Shallenberger to President of the Bone Growth Therapies business.

Business Wire last month
Orthofix Schedules Fourth Quarter and Full Year 2023 Earnings Release and Conference Call for March 5, 2024

LEWISVILLE, Texas, February 21, 2024--Orthofix Medical Inc. (NASDAQ:OFIX), a leading global spine and orthopedics company, today announced that it will release its fourth quarter and full year 2023 financial results on Tuesday, March 5, 2024 after market close. The Company will host a conference call and webcast to review results at 4:30 p.m. ET the same day.

Business Wire 2 months ago
Orthofix Announces Commercial Partnership with MRIguidance

LEWISVILLE, TEXAS, January 18, 2024--Surgeons and patients can now benefit from radiation-free preoperative imaging and spinal navigation with BoneMRI and the 7D FLASH Navigation System.

Business Wire 3 months ago
Julie Andrews Begins as New Chief Financial Officer at Orthofix

LEWISVILLE, Texas, January 16, 2024--Julie Andrews steps into the Chief Financial Officer role at Orthofix.

Business Wire 3 months ago
Orthofix Medical Inc. Announces Preliminary 2023 Fourth Quarter and Full-Year Net Sales Results

LEWISVILLE, Texas, January 09, 2024--Orthofix Medical Inc. (NASDAQ:OFIX), a leading global spine and orthopedics company, today announced preliminary unaudited fourth quarter 2023 net sales of approximately $200.3 million, an increase of 63.8% on a reported basis and 62.8% on a constant currency basis versus fourth quarter 2022. For the full year 2023, preliminary unaudited net sales were approximately $746.5 million, an increase of 62.0% on a reported basis and 61.5% on a constant currency basi

Business Wire 3 months ago
Orthofix Provides Executive Management Business Update and Appoints Julie Andrews as Chief Financial Officer

LEWISVILLE, Texas, January 08, 2024--Massimo Calafiore has assumed the role of President and CEO of Orthofix Medical Inc. and Julie Andrews has been appointed as CFO.

Business Wire 3 months ago
Orthofix Announces Publication of New Data Supporting Use of PEMF Stimulation in Lumbar Spine Fusion Procedures for Patients at Risk of Pseudarthrosis

LEWISVILLE, Texas, December 21, 2023--New data supports use of SpinalStim as adjunct therapy for patients at high risk of pseudarthrosis after lumbar spine fusion procedures.

Business Wire 4 months ago
Orthofix Announces Agreement with Engine Capital and Appointment of Three New Independent Directors to Further Advance Position as Leading Global Spine and Orthopedics Company

LEWISVILLE, Texas, December 12, 2023--Orthofix Medical Inc. (NASDAQ: OFIX) ("Orthofix" or the "Company") today announced the appointment of three new independent directors to the Company’s Board. These new directors bring substantial finance, strategic development, healthcare and medical technology experience to further advance Orthofix’s position as a leading global spine and orthopedics company. The appointments follow constructive engagement and entry into a cooperation agreement with Engine

Business Wire 4 months ago
Uber Technologies, Jabil and Builders FirstSource Set to Join S&P 500; Others to Join S&P MidCap 400 and S&P SmallCap 600

S&P Dow Jones Indices ("S&P DJI") will make the following changes to the S&P 500, S&P MidCap 400, and S&P SmallCap 600 indices effective prior to the open of trading on Monday, December 18, to coincide with the quarterly rebalance. The changes ensure each index is more representative of its market capitalization range. All companies being added to the S&P 500 are more representative of the large-cap market space, all companies being added to the S&P MidCap 400 are more representative of the mid-

PR Newswire 4 months ago
Orthofix Announces Publication in The Spine Journal of Five-Year Data for the M6-C Artificial Cervical Disc

LEWISVILLE, Texas, November 29, 2023--Five-year data for the M6-C artificial cervical disc published in The Spine Journal. M6-C and M6-L discs implantations reach 100,000 worldwide.

Business Wire 4 months ago
Orthofix Names Massimo Calafiore as President and Chief Executive Officer

LEWISVILLE, Texas, November 28, 2023--Orthofix Medical Inc. (NASDAQ:OFIX), a leading global spine and orthopedics company, announced today that Massimo Calafiore has been named incoming President and Chief Executive Officer. Mr. Calafiore is currently Chief Executive Officer of LimaCorporate S.p.A., a global orthopedics company, and his appointment to Orthofix is expected to be effective in early 2024, following the completion of LimaCorporate’s previously announced acquisition by Enovis Corpora

Business Wire 4 months ago
Orthofix Reports Third Quarter 2023 Results

LEWISVILLE, Texas, November 08, 2023--Orthofix Medical Inc. (NASDAQ:OFIX) today reported its financial results for the quarter ended September 30, 2023. Net sales were $184.0 million, earnings per share ("EPS") was $(0.77), and adjusted EPS was $0.07.

Business Wire 5 months ago
Orthofix Announces Full Commercial Launch of the WaveForm L Interbody System for Lateral Lumbar Fusion Procedures

LEWISVILLE, Texas, November 06, 2023--Orthofix Medical Inc. (NASDAQ:OFIX), a leading global spine and orthopedics company, today announced the full U.S. commercial launch of the WaveForm® L Lateral Lumbar Interbody System. Designed for lateral lumbar interbody fusion (LLIF) procedures, the 3D-printed WaveForm L features a porous structure that prioritizes strength and stability to provide a robust fusion environment.

Business Wire 5 months ago
Orthofix Schedules Third Quarter Earnings Release and Conference Call for November 8, 2023

LEWISVILLE, Texas, October 18, 2023--Orthofix Medical Inc. (NASDAQ:OFIX), a leading global spine and orthopedics company, today announced that it will release its third quarter 2023 financial results on Wednesday, November 8, 2023 after market close. The Company will host a conference call and webcast to review results at 4:30 p.m. ET the same day.

Business Wire 6 months ago
Orthofix Announces 510k Clearance and Full Commercial Launch of OsteoCove, an Advanced Bioactive Synthetic Graft for use in Spine and Orthopedic Procedures

LEWISVILLE, Texas, October 12, 2023--Orthofix receives 510k clearance and launches OsteoCove advanced bioactive synthetic graft for spine and orthopedic procedures.

Business Wire 6 months ago
Orthofix Announces First Patient Procedures and Full Commercial Launch of the Galaxy Fixation Gemini System and Expanded Sterile Kit Offerings for Orthopedic Trauma Procedures

LEWISVILLE, Texas, September 20, 2023--Orthofix expands sterile kit offerings for orthopedic trauma procedures with the U.S. launch of the Galaxy Fixation Gemini System.

Business Wire 7 months ago

Performance Overview

Return	OFIX	S&P 500
YTD	-3.64%	+6.92%
1-Year	-30.57%	+25.26%
3-Year	-71.00%	+22.00%

News

Life

Entertainment

Finance

Sports

New on Yahoo

Yahoo Finance

Orthofix Medical Inc. (OFIX)

Orthofix Schedules First Quarter 2024 Earnings Release and Conference Call for May 7, 2024

Orthofix Names Andres Cedron as New Chief Legal Officer

Lucas Vitale Joins Orthofix as Chief People and Business Operations Officer

Orthofix Reports Fourth Quarter and Full Year 2023 Results

Orthofix Announces New President for Bone Growth Therapies Business

Orthofix Schedules Fourth Quarter and Full Year 2023 Earnings Release and Conference Call for March 5, 2024

Orthofix Announces Commercial Partnership with MRIguidance

Julie Andrews Begins as New Chief Financial Officer at Orthofix

Orthofix Medical Inc. Announces Preliminary 2023 Fourth Quarter and Full-Year Net Sales Results

Orthofix Provides Executive Management Business Update and Appoints Julie Andrews as Chief Financial Officer

Orthofix Announces Publication of New Data Supporting Use of PEMF Stimulation in Lumbar Spine Fusion Procedures for Patients at Risk of Pseudarthrosis

Orthofix Announces Agreement with Engine Capital and Appointment of Three New Independent Directors to Further Advance Position as Leading Global Spine and Orthopedics Company

Uber Technologies, Jabil and Builders FirstSource Set to Join S&P 500; Others to Join S&P MidCap 400 and S&P SmallCap 600

Orthofix Announces Publication in The Spine Journal of Five-Year Data for the M6-C Artificial Cervical Disc

Orthofix Names Massimo Calafiore as President and Chief Executive Officer

Orthofix Reports Third Quarter 2023 Results

Orthofix Announces Full Commercial Launch of the WaveForm L Interbody System for Lateral Lumbar Fusion Procedures

Orthofix Schedules Third Quarter Earnings Release and Conference Call for November 8, 2023

Orthofix Announces 510k Clearance and Full Commercial Launch of OsteoCove, an Advanced Bioactive Synthetic Graft for use in Spine and Orthopedic Procedures

Orthofix Announces First Patient Procedures and Full Commercial Launch of the Galaxy Fixation Gemini System and Expanded Sterile Kit Offerings for Orthopedic Trauma Procedures

Performance Overview